Contact
Email: | |
---|---|
Phone: | +420 532 232 351 |
Research group: | Applied Neuroscience - Irena Rektorová |
Workplace: |
Masarykova univerzita - CEITEC Masarykova Univerzita
|
Publications that are part of the Web of Science database, possibly also other publications chosen by authors.
2020
- Labounek, R; Valosek, J; Horak, T; Svatkova, A; Bednarik, P; Vojtisek, L; Horakova, M; Nestrasil, I; Lenglet, C; Cohen-Adad, J; Bednarik, J; Hlustik, P, 2020: HARDI-ZOOMit protocol improves specificity to microstructural changes in presymptomatic myelopathy. SCIENTIFIC REPORTS 10(1), doi: 10.1038/s41598-020-70297-3
- Využití pokročilých magneticko-rezonančních technik k objasnění patofyziologie a zlepšení diagnostiky a praktického managementu degenerativní komprese krční míchy, Ministry of Health of the CR, 2018 - 2021
- Effect of intensive dance-exercise intervention on cognition and brain plasticity in healthy seniors and patients with mild cognitive impairment (15-33854A), Ministry of Health - Health research agency, 2015 - 2018
- ncRNAPain - Non-coding RNAs in neurogenic and neuropathic pain mechanisms and their application for risk assessment, patient stratification and personalised pain medicine (602133), Evropská unie, 2013 - 2017
- Identification of MRI based imaging biomarker in earlier detection of neuronal changes in animal models of Parkinson’s disease (4SGA8588), Jihomoravský kraj, 2015 - 2016
- Pre-clinical genotype-phenotype predictors of Alzheimer´s disease and other dementia (237250), Evropská unie, 2014 - 2016
- Multi-centre cohort-studies in Lewy-body dementia: Challenges in harmonizing different clinical and biomarker protocols, EU Joint Programme - Neurodegenerative Disease Research (JPND), 2014 - 2015
- Speech, its impairment and cognitive performance in Parkinson´s disease (NT/13499), Internal grant agency - Ministry of Health, 2012 - 2015
- Specific characteristics of neuropathic pain of central and peripheral type (NT/13523), Internal grant agency - Ministry of Health, 2012 - 2015
- Biomarkers for Alzheimer’s disease and Parkinson’s disease, EU Joint Programme - Neurodegenerative Disease Research (JPND), 2012 - 2015